Analyzing the Penicillins and Streptomycins in Dosage Market in Portugal reveals fluctuations over the past decade. In 2023, the market value was $50.167 million. The trend shows volatility, with the highest growth in 2017 at 26.29% and a significant decline in 2022 at -8.32%. Over the last five years, the compound annual growth rate (CAGR) is nearly flat at -0.0056%, indicating little overall growth.
Future trends to watch for:
- Potential market stabilization post-2023, following recent fluctuations.
- Opportunities for growth from new antibiotic innovations and resistance management strategies.
- Influences from healthcare policy changes regarding antibiotic prescription practices.
How does Portugal rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 18 | 18 Czech Republic | 60,391,000 | 2023 | -3.18% | -4.46% | View data |
| 19 | 19 New Zealand | 59,707,000 | 2023 | -1.18% | -1.53% | View data |
| 20 | 20 Portugal | 50,167,000 | 2023 | +0.83% | -0.0056% | |
| 21 | 21 Switzerland | 49,944,000 | 2023 | -1.64% | -1.63% | View data |
| 22 | 22 Guatemala | 39,329,000 | 2023 | +2.5% | +2.87% | View data |
